New drug TRX-100 tested in healthy people for first time
NCT ID NCT06757738
First seen Jan 25, 2026 · Last updated Jun 04, 2026 · Updated 21 times
Summary
This early-stage study tested a single dose of the experimental drug TRX-100 in 66 healthy adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either TRX-100 or a placebo. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Scientia Clinical Research
Sydney, Greater Sydney Area, NSW 2031, Australia
Conditions
Explore the condition pages connected to this study.